XML 31 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
1 Months Ended 11 Months Ended 12 Months Ended
Feb. 05, 2021
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2020
Cash flows from operating activities        
Net income (loss) $ 250,228,000 $ 101,982,000 $ 168,948,000 $ (3,978,459,000)
Adjustments to reconcile net loss to net cash flow from operating activities:        
Depreciation and amortization 20,622,000 89,535,000 146,879,000 374,129,000
Loss on impairment 0 0 0 3,915,408,000
Amortization of intangible assets and contract liabilities, net 0 51,540,000 (5,352,000) 0
(Gain) loss on extinguishment of debt, net 0 0 8,912,000 (17,254,000)
Gain on sale of operating assets, net 0 (185,934,000) (90,230,000) 0
Gain on bargain purchase 0 (62,305,000) 0 0
Reorganization items, net (280,790,000) 0 0 (17,366,000)
Deferred income taxes 2,501,000 (34,264,000) (25,628,000) (26,325,000)
Amortization of share-based compensation 710,000 16,510,000 35,251,000 9,169,000
Other costs, net (10,754,000) 1,146,000 (323,000) (61,550,000)
Changes in components of working capital        
Change in taxes receivable (1,789,000) 27,847,000 23,344,000 29,880,000
Net changes in other operating assets and liabilities (26,176,000) 45,559,000 19,184,000 45,565,000
Net cash provided by (used in) operating activities (45,448,000) 51,616,000 280,985,000 273,197,000
Cash flows from investing activities        
Capital expenditures (14,629,000) (154,411,000) (174,319,000) (148,886,000)
Cash acquired in stock-based business combinations, net 0 54,970,000 166,607,000 0
Proceeds from disposal of assets, net 194,000 307,324,000 381,026,000 27,366,000
Other investing activities 0 0 2,458,000 0
Net cash provided by (used in) investing activities (14,435,000) 207,883,000 375,772,000 (121,520,000)
Cash flows from financing activities        
Issuance of debt 200,000,000 0 350,000,000 0
Borrowings on credit facilities 177,500,000 40,000,000 220,000,000 210,000,000
Repayments of credit facilities (545,000,000) (217,500,000) (220,000,000) 0
Repayments of debt 0 0 (627,323,000) (101,132,000)
Compulsory purchase payment 0 0 (69,924,000) 0
Debt issuance costs (23,664,000) 0 (641,000) 0
Warrants exercised 0 730,000 1,004,000 0
Share Repurchases 0 0 (15,000,000) 0
Cash paid to settle equity awards 0 0 0 (1,010,000)
Taxes withheld on employee stock transactions (1,000) 0 (5,888,000) (418,000)
Net cash provided by (used in) financing activities (191,165,000) (176,770,000) (367,772,000) 107,440,000
Net increase (decrease) in cash, cash equivalents and restricted cash (251,048,000) 82,729,000 288,985,000 259,117,000
Cash, cash equivalents and restricted cash, beginning of period 365,041,000 113,993,000 196,722,000 105,924,000
Cash, cash equivalents and restricted cash, end of period $ 113,993,000 $ 196,722,000 $ 485,707,000 $ 365,041,000